Investigo Opens a New Office in New York

about 2 years ago Bianca Anderson

​We are extremely excited to announce the global expansion of Investigo into the US and introduce newly appointed Director, Craig Brown, who will lead the company’s growth into the Pharma and Life Sciences sector.

Craig has a proven track record of successfully launching two different recruitment businesses across multiple offices in America. He played an influential role in SThree Group’s expansion into the Pharma sector within the US, with their brand – Real Staffing. He brings a wealth of relevant knowledge, with extensive experience recruiting into the Pharma and Life Sciences sector.

Our US office, based in New York City, is set to quickly expand into a team of specialist recruiters who will offer a range of bespoke staffing solutions across the drug development, medical marketing and medical communications field. They will bring in-depth industry knowledge and experience recruiting into the Pharma and Life Sciences sector – continuing the expert level of service that Investigo is well known for.

Nick Baxter, CEO at Investigo, commented: ‘We are thrilled to have Craig on board and to be launching Investigo into a new location, New York. Craig is an outstanding fit for our business. With his US experience and expert knowledge of the Pharma and Life Sciences industry, he perfectly aligns with Investigo and our 2021 strategic mission – to become market leaders in each of our chosen specialisms. This is just the beginning of our exciting growth plans for the coming year, which will be achieved through attracting and retaining the best people in the market. Craig is a leader, an expert in his field and has the passion to grow a market leading business.’

If you’re currently working in Pharma and Life Sciences, or if you are excelling at your recruitment career and an opportunity to work in New York excites you, then please contact Victoria, Head of Talent Acquisition on the details below.

Email: victoria.hancock@investigo.co.uk

Telephone: +44 (0) 203 862 2869

Mobile: +44 (0) 7792 230 885